DTIL insider plans sale of 8,854 shares

An insider of DTIL filed a notice of proposed sale under Rule 144 for 8,854 common shares, with an aggregate market value of 35,653.29.

Rhea-AI Filing Summary

An insider of DTIL filed a notice of proposed sale under Rule 144 for 8,854 common shares, with an aggregate market value of 35,653.29. The shares are expected to be sold on 01/21/2026 on the NASDAQ through Fidelity Brokerage Services LLC. These shares were acquired on 01/20/2026 through restricted stock vesting from the issuer as compensation, rather than a cash purchase. The filing also reports that Dario J. Scimeca previously sold 665 common shares on 11/03/2025 for gross proceeds of 4,315.19. By signing the notice, the seller represents they are not aware of undisclosed material adverse information about the issuer’s operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does DTIL's latest Form 144 filing disclose?

The filing discloses that an insider plans to sell 8,854 shares of DTIL common stock with an aggregate market value of 35,653.29 on the NASDAQ under Rule 144.

Who is selling DTIL shares in this Form 144 and how many?

Dario J. Scimeca is identified as the seller, with a proposed sale of 8,854 common shares and a prior sale of 665 shares on 11/03/2025.

How were the DTIL shares in the Form 144 acquired?

The 8,854 DTIL common shares were acquired on 01/20/2026 through restricted stock vesting from the issuer as compensation, rather than through a cash purchase.

When and where are the DTIL shares expected to be sold?

The planned sale date is approximately 01/21/2026, with the shares to be sold on the NASDAQ through Fidelity Brokerage Services LLC in Smithfield, RI.

How many DTIL shares are outstanding according to the Form 144?

The Form 144 indicates there are 13,256,751 common shares of the issuer outstanding, providing a baseline for the size of the planned sale.

What prior DTIL stock sales are reported in the last 3 months?

The notice reports that 665 DTIL common shares were sold on 11/03/2025 for 4,315.19 in gross proceeds by Dario J. Scimeca.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/21/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001779581
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PRECISION BIOSCIENCES INC
SEC File Number	001-38841
Address of Issuer	302 EAST PETTIGREW STREET SUITE A-100 DURHAM NORTH CAROLINA 27701
Phone	919-314-5512
Name of Person for Whose Account the Securities are To Be Sold	Scimeca Dario
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8854	35653.29	13256751	01/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/20/2026	Restricted Stock Vesting	Issuer			8854	01/20/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Dario J. Scimeca 302 East Pettigrew St Suite A-100 Durham NC 27701	Common	11/03/2025	665	4315.19

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	01/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Dario Scimeca
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)